Quarter Financials
Avidity Biosciences, Inc. (RNA)
$11.15
+0.28 (+2.58%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -50 | -44 | -46 | -34 | -39 | -29 | -26 | -24 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -359 | -308 | -264 | -219 | -185 | -146 | -117 | -90 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | 0 | - | -1 | -1 | 2 | -1 | -1 | -1 |
|---|
| Net PPE | 15 | 15 | 16 | 15 | 16 | 3 | 3 | 2 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | -85 | -175 | -38 | -54 | -90 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|